Skip to content

Pulmonx Corporation LUNG Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$61.03M-2.4%$68.71M+6.9%$73.04M+34.9%$72.32M+26.3%$62.54M+8.1%
$10.83M-22.5%$12.07M-8.0%$13.8M+18.2%$15.9M+43.5%$13.98M+32.8%
$3.82M+178%$3.6M+114%$2.47M+9.2%$1.89M-17.7%$1.38M-45.4%
$92.75M-25.2%$101.68M-25.4%$111.24M-21.1%$120.02M-17.9%$123.94M-16.2%
$2.06M-27.1%$2.22M-23.6%$2.44M-18.1%$2.66M-6.0%$2.83M-33.0%
$2.33M0.0%$2.33M0.0%$2.33M0.0%$2.33M0.0%$2.33M0.0%
$119.97M-20.4%$129.29M-20.6%$138.28M-17.4%$147.19M-14.7%$150.74M-8.4%
$3.47M-18.8%$3.91M+2.0%$6.42M+40.3%$6.56M+106%$4.28M+37.0%
$32K-75.0%$18K-86.7%$92K-15.6%$78K-27.1%$128K+16.4%
$104K-98.7%$106K-96.7%$105K+6.1%$104K+11.8%$7.8M+49.2%
$104K-98.7%$106K-96.7%$105K+6.1%$104K+11.8%$7.8M+49.2%
$18.91M-24.2%$20.06M-17.9%$22.88M+25.0%$22.45M+37.7%$24.95M+17.1%
$37.21M+26.6%$36.99M+8.8%$37.03M-0.3%$37.01M-0.3%$29.39M-8.2%
$74.21M+1.6%$75.18M-2.4%$78.25M+6.5%$78.1M+9.3%$73.07M+35.1%
200M0.0%200M+499,900%200M0.0%200M0.0%200M0.0%
-$535.21M-11.0%-$521.56M-11.6%-$511.13M-12.5%-$497.18M-12.9%-$482M-13.4%
$45.76M-41.1%$54.12M-36.9%$60.03M-36.1%$69.09M-31.7%$77.67M-29.7%
$119.97M-20.4%$129.29M-20.6%$138.28M-17.4%$147.19M-14.7%$150.74M-8.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Pulmonx Corporation's total assets?
Pulmonx Corporation (LUNG) holds $120.0M in total assets, down 20.4% year over year.
How much debt does Pulmonx Corporation have?
Pulmonx Corporation carries $56.3M in total debt against $45.8M of shareholders' equity, a debt-to-equity ratio of 1.23.
How much cash does Pulmonx Corporation have?
Pulmonx Corporation holds $61.0M in cash and equivalents.
Can Pulmonx Corporation cover its short-term obligations?
Its current ratio is 4.91 — current assets exceed current liabilities.
Where does Pulmonx Corporation's balance sheet data come from?
Every line is extracted from Pulmonx Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.